AlzBiomarker
MCI-AD vs MCI-Stable: sAPPβ (CSF)
Meta-analysis Results: Baseline CSF levels of sAPPβ did not differ between people with mild cognitive impairment who went on to develop Alzheimer’s dementia and those who did not decline at follow-up. The meta-analysis is limited to three studies (effect size = 1.055, p = 0.58568).

